In Vitro Activity of Ceftobiprole and Comparator Agents Against Contemporary U.S. Clinical Isolates Collected in 2025 Following FDA Approval
In Vitro Activity of Ceftobiprole and Comparator Agents Against Contemporary U.S. Clinical Isolates Collected in 2025 Following FDA Approval. Lead author: Rodrigo E. Mendes, presented at IDWeek 2026, Oct 22, Washington D.C., USA
Poster P-142
